| Dr Erick Schuermann, DO | |
|
315 S Osteopathy Ave, Kirksville, MO 63501-6401 | |
| (660) 785-1098 | |
| Not Available |
| Full Name | Dr Erick Schuermann |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 315 S Osteopathy Ave, Kirksville, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558630269 | NPI | - | NPPES |
| 1558630269 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2011019877 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Bernards Medical Center | Jonesboro, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jonesboro Anesthesia Inc | 6709798077 | 43 |
News Archive
Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
› Verified 7 days ago
| Entity Name | Jonesboro Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043228448 PECOS PAC ID: 6709798077 Enrollment ID: O20031104000602 |
News Archive
Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
› Verified 7 days ago
| Entity Name | Premier Anesthesia Of Arkansas Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932519485 PECOS PAC ID: 6406077460 Enrollment ID: O20141016002060 |
News Archive
Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erick Schuermann, DO Po Box 1930, Jonesboro, AR 72403-1930 Ph: (870) 934-5102 | Dr Erick Schuermann, DO 315 S Osteopathy Ave, Kirksville, MO 63501-6401 Ph: (660) 785-1098 |
News Archive
Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
› Verified 7 days ago
Dr. Jonathan David Easterwood, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1205 | |
Nathan Joseph Conrad Needham, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. Joshua Douglas Blanchard, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2302 Oak Ln, Kirksville, MO 63501 Phone: 517-303-3986 | |
Damon Morris, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Melvin C Roof, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 800 W Jefferson St, Northeast Regional Medical Center, Kirksville, MO 63501 Phone: 660-785-1000 Fax: 660-785-1237 | |
Dr. Elizabeth Mary Roberts, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 |